Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRAF vs RAS oncogenes: are mutations of the same pathway equal? differential signalling and therapeutic implications
Eftychia Oikonomou, Evangelos Koustas, Maria Goulielmaki, et al.
Oncotarget (2014) Vol. 5, Iss. 23, pp. 11752-11777
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong, Francesca Finotello, Mihaela Angelova, et al.
Cell Reports (2017) Vol. 18, Iss. 1, pp. 248-262
Open Access | Times Cited: 3660
Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality
Veronica Aran, Ana Paula Victorino, Luiz Cláudio Santos Thuler, et al.
Clinical Colorectal Cancer (2016) Vol. 15, Iss. 3, pp. 195-203
Closed Access | Times Cited: 337
Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade
Pornpimol Charoentong, Francesca Finotello, Mihaela Angelova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2016)
Open Access | Times Cited: 308
Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
Georgios Antonios Margonis, Stefan Buettner, Nikolaos Andreatos, et al.
JAMA Surgery (2018) Vol. 153, Iss. 7, pp. e180996-e180996
Open Access | Times Cited: 176
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
Gregory P. Way, Francisco Sánchez-Vega, Konnor La, et al.
Cell Reports (2018) Vol. 23, Iss. 1, pp. 172-180.e3
Open Access | Times Cited: 156
Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance
Markus Morkel, Pamela Riemer, Hendrik Bläker, et al.
Oncotarget (2015) Vol. 6, Iss. 25, pp. 20785-20800
Open Access | Times Cited: 132
Important molecular genetic markers of colorectal cancer
Anna V. Kudryavtseva, Anastasiya V. Lipatova, Andrew R. Zaretsky, et al.
Oncotarget (2016) Vol. 7, Iss. 33, pp. 53959-53983
Open Access | Times Cited: 100
Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors
Wagner R. Montor, Andrei Ronaldo Oliveira Silva Escar Salas, Fabiana Henriques Machado de Melo
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 94
Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases
Georgios Antonios Margonis, Stefan Buettner, Nikolaos Andreatos, et al.
Annals of Surgery (2018) Vol. 269, Iss. 6, pp. 1129-1137
Closed Access | Times Cited: 84
The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and Progression
Filippo Torrisi, Cristiana Alberghina, Simona D’Aprile, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 806-806
Open Access | Times Cited: 65
Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review
Bethsebie Lalduhsaki Sailo, Le Liu, Suravi Chauhan, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 244-244
Open Access | Times Cited: 13
Ultraviolet Radiation Biological and Medical Implications
Tarek Al-Sadek, Nabiha Yusuf
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 3, pp. 1924-1942
Open Access | Times Cited: 12
MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis
Jar‐Yi Ho, Ren‐Jun Hsu, Jui‐Ming Liu, et al.
Oncotarget (2016) Vol. 8, Iss. 14, pp. 22443-22459
Open Access | Times Cited: 77
Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer
Evangelos Koustas, Michalis V. Karamouzis, Chrysovalantou Mihailidou, et al.
Cancer Letters (2017) Vol. 396, pp. 94-102
Closed Access | Times Cited: 65
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
Stéphanie Lheureux, Christophe Denoyelle, Pamela S. Ohashi, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2017) Vol. 44, Iss. S1, pp. 41-54
Open Access | Times Cited: 64
Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity
Khaleel I. Al‐Obaidy, John N. Eble, Mehdi Nassiri, et al.
Modern Pathology (2019) Vol. 33, Iss. 6, pp. 1157-1164
Open Access | Times Cited: 56
KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways
Koushik Mondal, Mahesh Kumar Posa, Revathi P Shenoy, et al.
Cells (2024) Vol. 13, Iss. 14, pp. 1221-1221
Open Access | Times Cited: 7
Colorectal Cancer Biomarkers in the Era of Personalized Medicine
Jai N. Patel, Mei Ka Fong, Megan H. Jagosky
Journal of Personalized Medicine (2019) Vol. 9, Iss. 1, pp. 3-3
Open Access | Times Cited: 45
Concomitant KRAS and BRAF mutations in colorectal cancer
Lauren Midthun, Shagufta Shaheen, Jeremy Deisch, et al.
Journal of Gastrointestinal Oncology (2019) Vol. 10, Iss. 3, pp. 577-581
Open Access | Times Cited: 45
The Interplay of Autophagy and Tumor Microenvironment in Colorectal Cancer—Ways of Enhancing Immunotherapy Action
Evangelos Koustas, Panagiotis Sarantis, Georgia Kyriakopoulou, et al.
Cancers (2019) Vol. 11, Iss. 4, pp. 533-533
Open Access | Times Cited: 44
Unraveling BRAF alterations: molecular insights to circumvent therapeutic resistance across cancer types
Caterina Perfetto, Marianna Aprile, Simona Cataldi, et al.
Cancer Drug Resistance (2025)
Open Access
A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance
Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 4
RAS/RAFlandscape in monoclonal plasma cell conditions.
Anaïs Schavgoulidze, Jill Corre, Mehmet Samur, et al.
Blood (2024) Vol. 144, Iss. 2, pp. 201-205
Closed Access | Times Cited: 4
Validation of targeted next-generation sequencing forRASmutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR
Jie Gao, Huanwen Wu, Li Wang, et al.
BMJ Open (2016) Vol. 6, Iss. 1, pp. e009532-e009532
Open Access | Times Cited: 38
Breast Cancer Heterogeneity Examined by High-Sensitivity Quantification of PIK3CA, KRAS, HRAS, and BRAF Mutations in Normal Breast and Ductal Carcinomas
Meagan B. Myers, Malathi Banda, Karen L. McKim, et al.
Neoplasia (2016) Vol. 18, Iss. 4, pp. 253-263
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top